Callitas Therapeutics

Create an alert
to follow the executive moves at Callitas Therapeutics.

Most searched biographies at Callitas Therapeutics

• James Thompson, Chief Executive Officer
• Richard Skeith, Director
• Christopher Andrews, Director

Click on an executive to view his biography >

Latest M&A news in Biotechnology.

Roivant Sciences has announced the acquisition of Silicon Therapeutics (posted on Feb 26, 2021).
Merck has announced the acquisition of Pandion Therapeutics (posted on Feb 26, 2021).
Charles River Laboratories International has announced the acquisition of Cognate BioServices (posted on Feb 18, 2021).

Other contacts in the Biotechnology industry

• Tal Zaks - Non-Executive Director at Adaptimmune Therapeutics
• Chandra Leo - Director at Gynesonics
• Stephen Hoge - Director at Axcella Health

Learn more about the Biotechnology industry >

Latest news about Callitas Therapeutics

Callitas Therapeutics on Wikipedia, Google News & Yahoo Finance

Callitas Therapeutics on LinkedIn, Twitter & YouTube

Callitas Therapeutics has 1,568 competitors including Biogen (United States (USA)), Neptune Wellness Solutions (Canada) and Eurofins (France).

Contact by email its executives including James Thompson

Call Callitas Therapeutics at +1 604....

View the org chart

Register to receive your alert

Report an error